Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes - PubMed
Although immune-checkpoint inhibitors (ICIs) have significantly improved cancer treatment, their effectiveness is limited by primary or acquired resistance in many patients. The gut microbiota, through its production of metabolites and regulation of immune cell functions, plays a vital role in maint …